Jiangsu Yong'an Pharmaceutical Co Ltd.

Main study objectives: To investigate the relative bioavailability of the test preparation Diacerein Capsules (specification: 50 mg, produced by Jiangsu Yongan Pharmaceutical Co., Ltd.) and the reference preparation Diacerein Capsules (trade name: Ambide®, specification: 50 mg, licensed by TRB Pharma S.A.) in healthy Chinese adults after a single oral administration on an empty stomach/after a meal, analyze the pharmacokinetic parameters of the two preparations, and evaluate the bioequivalence of the two preparations. Secondary study objectives: To evaluate the safety of the test preparation and the reference preparation in healthy Chinese adults after a single oral administration on an empty stomach/after a meal.